Saturday, July 11, 2026

biotech · Breast Cancer · Pleural carcinosis · SANA

Sana Biotechnology

Sana Biotechnology is a biotech organization headquartered in Seattle, USA. It trades on NYSE under ticker SANA. Primary therapeutic focus areas include Breast Cancer, Pleural carcinosis, Parkinson’s Disease, Graves' dis

188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA · NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
22
Patents
136
Clinical program

Sana Device (Control)

Unknown · small molecule · Fibromyalgia

Sana Device (Control) for Fibromyalgia is a Unknown program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).

← All Sana Biotechnology projects Unknown small molecule terminated

Internal code 850524

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sana Biotechnology
Phase
Unknown
Modality
small_molecule
Indication
Fibromyalgia
Status
terminated
Trials
1